Freshfields Bruckhaus Deringer has advised Novartis AG on the sale of its 36.5% stake in its consumer health joint venture with GlaxoSmithKline plc for US$13bn. The…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now